Literature DB >> 23791569

Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.

Aldo Moreno-Ulloa1, Armando Cid, Ivan Rubio-Gayosso, Guillermo Ceballos, Francisco Villarreal, Israel Ramirez-Sanchez.   

Abstract

Impaired mitochondrial function represents an early manifestation of endothelial dysfunction and likely contributes to the development of cardiovascular diseases (CVD). The stimulation of mitochondrial function and/or biogenesis is seen as a means to improve the bioenergetic and metabolic status of cells and thus, reduce CVD. In this study we examined the capacity of the flavanol (-)-epicatechin and two novel derivatives to enhance mitochondrial function and protein levels in cultured bovine coronary artery endothelial cells. As nitric oxide production by endothelial cells is suspected in mediating mitochondria effects (including biogenesis), we also examined the dependence of responses on this molecule using an inhibitor of nitric oxide synthase. Results indicate that the flavanol (-)-epicatechin and derivatives are capable of stimulating mitochondrial function as assessed by citrate synthase activity as well as induction of structural (porin, mitofilin) and oxidative phosporylation protein levels (complex I and II). Effects were blocked by the use of the chemical inhibitor of the synthase thus, evidencing a role for nitric oxide in mediating these effects. The results observed indicate that the three agents are effective in enhancing mitochondria function and protein content. The effects noted for (-)-epicatechin may serve to explain the healthy effects on cardiometabolic risk ascribed to the consumption of cocoa products.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23791569      PMCID: PMC3741049          DOI: 10.1016/j.bmcl.2013.05.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  38 in total

1.  Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells.

Authors:  Vitor A Lira; Dana L Brown; Ana K Lira; Andreas N Kavazis; Quinlyn A Soltow; Elizabeth H Zeanah; David S Criswell
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

2.  Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation.

Authors:  J P Spencer; H Schroeter; G Kuhnle; S K Srai; R M Tyrrell; U Hahn; C Rice-Evans
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise.

Authors:  J O Holloszy; L B Oscai; I J Don; P A Molé
Journal:  Biochem Biophys Res Commun       Date:  1970-09-30       Impact factor: 3.575

4.  Exercise-induced ultrastructural changes in skeletal muscle.

Authors:  H Hoppeler
Journal:  Int J Sports Med       Date:  1986-08       Impact factor: 3.118

5.  Plasma kinetics in man of epicatechin from black chocolate.

Authors:  M Richelle; I Tavazzi; M Enslen; E A Offord
Journal:  Eur J Clin Nutr       Date:  1999-01       Impact factor: 4.016

6.  Mitochondrial enzymes increase in muscle in response to 7-10 days of cycle exercise.

Authors:  R J Spina; M M Chi; M G Hopkins; P M Nemeth; O H Lowry; J O Holloszy
Journal:  J Appl Physiol (1985)       Date:  1996-06

7.  Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

Authors:  Enzo Nisoli; Emilio Clementi; Clara Paolucci; Valeria Cozzi; Cristina Tonello; Clara Sciorati; Renata Bracale; Alessandra Valerio; Maura Francolini; Salvador Moncada; Michele O Carruba
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

Review 8.  Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport.

Authors:  Alisdair R Fernie; Fernando Carrari; Lee J Sweetlove
Journal:  Curr Opin Plant Biol       Date:  2004-06       Impact factor: 7.834

Review 9.  Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease.

Authors:  María C Carreras; María C Franco; Jorge G Peralta; Juan J Poderoso
Journal:  Mol Aspects Med       Date:  2004 Feb-Apr

10.  Regionalized pathology correlates with augmentation of mtDNA copy numbers in a patient with myoclonic epilepsy with ragged-red fibers (MERRF-syndrome).

Authors:  Anja Brinckmann; Claudia Weiss; Friederike Wilbert; Arpad von Moers; Angelika Zwirner; Gisela Stoltenburg-Didinger; Ekkehard Wilichowski; Markus Schuelke
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

View more
  17 in total

Review 1.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

Review 2.  Therapies for mitochondrial diseases and current clinical trials.

Authors:  Ayman W El-Hattab; Ana Maria Zarante; Mohammed Almannai; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2017-09-18       Impact factor: 4.797

Review 3.  Advances in drug therapy for mitochondrial diseases.

Authors:  Lufei Zhang; Zhaoyong Zhang; Aisha Khan; Hui Zheng; Chao Yuan; Haishan Jiang
Journal:  Ann Transl Med       Date:  2020-01

4.  (-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor.

Authors:  Aldo Moreno-Ulloa; Adriana Miranda-Cervantes; Alexei Licea-Navarro; Christina Mansour; Ernesto Beltrán-Partida; Luis Donis-Maturano; Hilda C Delgado De la Herrán; Francisco Villarreal; Carolina Álvarez-Delgado
Journal:  Eur J Pharmacol       Date:  2018-01-20       Impact factor: 4.432

Review 5.  ( -)-Epicatechin and cardiometabolic risk factors: a focus on potential mechanisms of action.

Authors:  Ezequiel J Hid; Juana I Mosele; Paula D Prince; Cesar G Fraga; Monica Galleano
Journal:  Pflugers Arch       Date:  2021-11-23       Impact factor: 3.657

6.  Synthesis of novel (-)-epicatechin derivatives as potential endothelial GPER agonists: Evaluation of biological effects.

Authors:  Viviana Sarmiento; Israel Ramirez-Sanchez; Aldo Moreno-Ulloa; Diego Romero-Perez; Daniel Chávez; Miguel Ortiz; Nayelli Najera; Jose Correa-Basurto; Francisco Villarreal; Guillermo Ceballos
Journal:  Bioorg Med Chem Lett       Date:  2018-01-24       Impact factor: 2.823

7.  (-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase.

Authors:  Israel Ramírez-Sánchez; Alonso Rodríguez; Aldo Moreno-Ulloa; Guillermo Ceballos; Francisco Villarreal
Journal:  Diab Vasc Dis Res       Date:  2016-03-18       Impact factor: 3.291

8.  The effects of (-)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER).

Authors:  Aldo Moreno-Ulloa; David Mendez-Luna; Ernesto Beltran-Partida; Carmen Castillo; Gustavo Guevara; Israel Ramirez-Sanchez; José Correa-Basurto; Guillermo Ceballos; Francisco Villarreal
Journal:  Pharmacol Res       Date:  2015-08-21       Impact factor: 7.658

9.  Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.

Authors:  Georgina Almaguer; Pilar Ortiz-Vilchis; Paola Cordero; Rocío Martinez-Vega; Javier Perez-Durán; Eduardo Meaney; Francisco Villarreal; Guillermo Ceballos; Nayelli Nájera
Journal:  J Pharm Pharmacol       Date:  2021-12-07       Impact factor: 4.810

Review 10.  Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine.

Authors:  Icksoo Lee
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.